Saturday, 12 September 2015 14:00

Dermatologist sparks research

Written by 
Dermatologist, Dr Ingrid Karin Lopez-Gehrke and Dr Rod Claycomb, Quantec. Dermatologist, Dr Ingrid Karin Lopez-Gehrke and Dr Rod Claycomb, Quantec.

The curiosity of a Mexican dermatologist has sparked new anti-acne research.

It may also hold the key to further success for Hamilton-based Quantec Ltd, developers of a clinically-proven anti-acne cream called Epiology Skincare derived from high value milk proteins.

Quantec founder and managing director Dr Rod Claycomb says one simple question has led his research and development team to confirm the patented ingredient in Epiology Skincare kills the bad bacteria that causes acne but does not kill naturally-found good bacteria required for healthy skin.

“We launched Epiology Skincare onto the Mexican market in December 2014 through a strong national network of dermatologists.  One of those dermatologists, Dr Ingrid Karin Lopez-Gehrke, performed some clinical studies on her patients.  

“Those patient experiences led her to ask our R&D team if it was possible that Epiology kills the bad bacteria on your skin that causes acne but does not kill the good bacteria your skin requires to be healthy.

“This was something we suspected but never thoroughly tested so her question sent us back into the lab to run new experiments.  We concluded Dr Ingrid’s suspicions were factual: in the process of killing the bad bacteria that causes acne – P. acnes – Epiology does not kill commensals, or good bacteria naturally found on healthy skin,” Claycomb says.

Dr Lopez-Gehrke, a key opinion leader among Mexican dermatologists, was invited to present the results of Epiology clinical experiences at the New Zealand Dermatological Society annual meeting on Saturday, August 28 in Auckland.

Lopez-Gehrke led a study of the unique ability of Epiology to reduce redness and protect patient’s skin from known harsh effects of prescription acne medications.

According to statistics provided by Quantec’s Mexican distributor, 80-90% of the country’s population is affected by acne before the age of 21 and many will contact a dermatologist. Mexican dermatologists derive around one-third of their income from selling branded derma products. 

Claycomb believes the distribution of Epiology into Mexico is a good entry point for the company to launch into other Central American and Latin American markets in the medium term.

More like this

Biotech firm again wins top award

Hamilton dairy biotech company Quantec has won the top award at the annual Natural Health Products NZ awards for the second year running.

Featured

$52,500 fine for effluent mismanagement

A Taupiri farming company has been convicted and fined $52,500 in the Hamilton District Court for the unlawful discharge of dairy effluent into the environment.

Ospri brings Bovine TB testing in-house

The move to bring bovine TB testing in-house at Ospri officially started this month, as a team of 37 skilled and experienced technicians begin work with the disease eradication agency.

National

Machinery & Products

Fliegl offers effluent solutions

Founded in Germany as recently as 1977, today, the Fliegl Group employs more than 1100 workers, offering an expansive range…

» Latest Print Issues Online

Milking It

It's all about economics

OPINION: According to media reports, the eye-watering price of butter has prompted Finance Minister Nicola Willis to ask for a…

» Connect with Dairy News

» eNewsletter

Subscribe to our weekly newsletter